Состав:
Применение:
Применяется при лечении:
Страница осмотрена фармацевтом Олейник Елизаветой Ивановной Последнее обновление 26.06.2023

Внимание! Информация на странице предназначена только для медицинских работников! Информация собрана в открытых источниках и может содержать значимые ошибки! Будьте внимательны и перепроверяйте всю информацию с этой страницы!
Топ 20 лекарств с такими-же компонентами:
Топ 20 лекарств с таким-же применением:
Phentermine hydrochloride is indicated in the management of exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction. The limited usefulness of agents of this class (see CLINICAL PHARMACOLOGY) should be measured against possible risk factors inherent in their use.
Redusa is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 30 kg/m² , or greater than or equal to 27 kg/m² in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia).
Below is a chart of body mass index (BMI) based on various heights and weights.
BMI is calculated by taking the patient's weight, in kilograms (kg), divided by the patient's height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters.
BODY MASS INDEX (BMI), kg/m²
Height (feet, inches) | ||||||
Weight (pounds) | 5'0” | 5'3” | 5'6” | 5'9” | 6'0” | 6'3” |
140 | 27 | 25 | 23 | 21 | 19 | 18 |
150 | 29 | 27 | 24 | 22 | 20 | 19 |
160 | 31 | 28 | 26 | 24 | 22 | 20 |
170 | 33 | 30 | 28 | 25 | 23 | 21 |
180 | 35 | 32 | 29 | 27 | 25 | 23 |
190 | 37 | 34 | 31 | 28 | 26 | 24 |
200 | 39 | 36 | 32 | 30 | 27 | 25 |
210 | 41 | 37 | 34 | 31 | 29 | 26 |
220 | 43 | 39 | 36 | 33 | 30 | 28 |
230 | 45 | 41 | 37 | 34 | 31 | 29 |
240 | 47 | 43 | 39 | 36 | 33 | 30 |
250 | 49 | 44 | 40 | 37 | 34 | 31 |
The limited usefulness of agents of this class, including Redusa, should be measured against possible risk factors inherent in their use such as those described below.